(0.53%) 5 073.00 points
(0.40%) 38 222 points
(0.64%) 17 550 points
(0.66%) $79.52
(1.60%) $1.963
(0.68%) $2 326.60
(0.33%) $26.84
(1.58%) $970.00
(-0.02%) $0.933
(0.00%) $11.03
(-0.03%) $0.798
(-0.74%) $92.57
3.70% $ 0.0280
Live Chart Being Loaded With Signals
Pharmaxis Ltd engages in the research, development, and commercialization of healthcare products for the treatment of fibrotic and inflammatory diseases worldwide...
Stats | |
---|---|
Dzisiejszy wolumen | 304.00 |
Średni wolumen | 176 420 |
Kapitalizacja rynkowa | 20.23M |
EPS | $0 ( 2024-02-07 ) |
Następna data zysków | ( $0 ) 2024-07-29 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.400 |
ATR14 | $0.00100 (5.26%) |
Wolumen Korelacja
Pharmaxis Ltd Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Pharmaxis Ltd Korelacja - Waluta/Towar
Pharmaxis Ltd Finanse
Annual | 2022 |
Przychody: | $5.77M |
Zysk brutto: | $3.06M (53.06 %) |
EPS: | $-0.0173 |
FY | 2022 |
Przychody: | $5.77M |
Zysk brutto: | $3.06M (53.06 %) |
EPS: | $-0.0173 |
FY | 2022 |
Przychody: | $7.43M |
Zysk brutto: | $7.43M (100.00 %) |
EPS: | $0.0205 |
FY | 2021 |
Przychody: | $6.68M |
Zysk brutto: | $6.68M (100.00 %) |
EPS: | $-0.00700 |
Financial Reports:
No articles found.
Pharmaxis Ltd
Pharmaxis Ltd engages in the research, development, and commercialization of healthcare products for the treatment of fibrotic and inflammatory diseases worldwide. The company operates through two segments, Mannitol Respiratory Business and New Drug Development. It offers Bronchitol, an inhaled dry powder for the treatment of cystic fibrosis; and Aridol, an airways inflammation test that is used to identify twitchy or hyper-responsive airways, as well as to assist in diagnosing and managing asthma. The company's product pipeline consists of oral pan-lysyl oxidase inhibitors (LOX) targeting myelofibrosis and other cancers; topical pan-LOX inhibitors targeting skin scarring after events, such as accidents, surgery,and burns; selective Lysyl Oxidase Like Inhibitors (LOXL2) targeting chronic fibrotic diseases, including kidney fibrosis, pulmonary fibrosis, liver fibrosis, and cardiac fibrosis; and semicarbazide-sensitive amine oxidase for neuro inflammatory diseases. It is also developing Orbital, a dry powder inhaler to deliver high drug doses to lungs. Pharmaxis Ltd was incorporated in 1998 and is headquartered in Frenchs Forest, Australia.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej